Singapore start-up uses body's immune cells to fight cancer

CytoMed says it has found a way to combine arsenal of cells, grow them in large quantities

(From left) CytoMed Therapeutics' senior research scientist Richard Zha, 28, chief operating officer Tan Wee Kiat, 32, chief scientific officer Zeng Jieming, 46, research officer Du Zhi Cheng, 24, and manager Evelyn Tan, 31. The start-up deals in cel
(From left) CytoMed Therapeutics' senior research scientist Richard Zha, 28, chief operating officer Tan Wee Kiat, 32, chief scientific officer Zeng Jieming, 46, research officer Du Zhi Cheng, 24, and manager Evelyn Tan, 31. The start-up deals in cellular immunotherapy and stem cell research and therapy. ST PHOTO: NG SOR LUAN
New: Gift this subscriber-only story to your friends and family

They are the ninjas of the body.

Natural killer (NK) cells and gamma delta T-cells are the elite assassins among the soldiers that fight disease from within. They have the ability to swiftly locate and kill interlopers which threaten the body, such as different types of tumour cells.

Already a subscriber? 

Dive deeper at $0.99/month

Want more exclusives, sharp insights into what's happening at home and abroad? Subscribe to stay informed.

Unlock these benefits

  • All subscriber-only content on ST app and straitstimes.com

  • Easy access any time via ST app on 1 mobile device

  • 2-week e-paper archive so you never miss out on any topic that matters to you

Join ST's Telegram channel and get the latest breaking news delivered to you.

A version of this article appeared in the print edition of The Straits Times on May 04, 2019, with the headline Singapore start-up uses body's immune cells to fight cancer. Subscribe